A

s new technologies help scientists automate and miniaturize experiments, companies are getting better at streamlining the drug discovery process. This week brought two new examples.

In one study, published Thursday in the journal Science, researchers at Pfizer described a new system that allows chemists to run thousands of reactions much faster than they could previously to determine the best way to produce the greatest amount of desired compounds.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.